May 7, 2010 12:09
14 yrs ago
9 viewers *
English term
A Phase II/III adaptive seamless design study
English to Russian
Medical
Medical: Pharmaceuticals
clinical trials
Помогите, пожалуйста, перевести название исследования.
A Phase II/III adaptive seamless design study with the first stage providing the definitive evidence for dose selection, and the second stage providing pivotal 6-month efficacy data with the chosen doses versus open-label tiotropium and blinded placebo, and 24-hour profiles of lung function for these chosen doses.
Заранее благодарю за помощь.
A Phase II/III adaptive seamless design study with the first stage providing the definitive evidence for dose selection, and the second stage providing pivotal 6-month efficacy data with the chosen doses versus open-label tiotropium and blinded placebo, and 24-hour profiles of lung function for these chosen doses.
Заранее благодарю за помощь.
Proposed translations
(Russian)
| 3 +3 | адаптивное непрерывное исследование фазы II/III |
mas63
|
| 4 | непрерывное исследование фазы II и III с адаптивным планом |
Pavel Venediktov
|
Proposed translations
+3
7 mins
Selected
адаптивное непрерывное исследование фазы II/III
или непрерывное исследование фазы II/III с адаптивным дизайном
seamless - бесшовный, но говорить "бесшовное исследование" было бы слишком смело:)
seamless - бесшовный, но говорить "бесшовное исследование" было бы слишком смело:)
4 KudoZ points awarded for this answer.
Comment: "спасибо"
10 mins
Pavel Venediktov
Russian Federation
Russian Federation
Native in Russian
Specializes in field
Russian Federation
35 years in science & 15 in translation
Native in: Russian 
Works in: English to Russian
Related KudoZ points
:
1149
непрерывное исследование фазы II и III с адаптивным планом
adaptive design - study procedures that change as the study progresses. Most often refers to the details of the randomisation process changing as the study progresses and results become known. Such designs are used so that, if it appears that one treatment is emerging as superior to another, the allocation ratio can be biased in favour of the treatment that seems to be best.
Something went wrong...